Haitian cohort (N = 1345) | |
---|---|
CVD Risk Estimation Method | N (%) |
Pooled Cohort Equations (PCE) | |
Median (25th to 75th percentile) | 6.1 [2.7, 12.2] |
Low risk (< 5%) | 588 (43.7) |
Intermediate (5 to < 7.5%) | 200 (14.9) |
High (≥ 7.5%) | 557 (41.4) |
Statin eligibilitya | 563 (41.9) |
adjusted Pooled Cohort Equations (adjusted PCE) | |
Median (25th to 75th percentile) | 3.6 [1.7, 8.2] |
Low risk (< 5%) | 813 (60.4) |
Intermediate (5 to < 7.5%) | 164 (12.2) |
High (≥ 7.5%) | 368 (27.4) |
Statin eligibilitya | 408 (30.3) |
Framingham-Lipids | |
Median (25th to 75th percentile) | 8.2 [4.2, 16.4] |
Low (< 10%) | 776 (57.7) |
Intermediate (10 to < 20%) | 327 (24.3) |
High (≥ 20%) | 242 (18.0) |
Statin eligibilitya | 344 (25.6) |
Framingham-BMI | |
Median (25th to 75th percentile) | 9.6 [4.9, 18.0] |
Low (< 10%) | 689 (51.2) |
Intermediate (10 to < 20%) | 360 (26.8) |
High (≥ 20%) | 296 (22.0) |
Statin eligibilitya | 362 (27.0) |
WHO-Lipids | |
Median (25th to 75th percentile) | 4.0 [2.0, 8.0] |
Low risk (< 5%) | 685 (50.9) |
Intermediate-high-risk (5 to < 20%) | 627 (46.6) |
High (≥ 20%) | 33 (2.5) |
Statin eligibilitya | 33 (2.5) |
WHO-BMI | |
Median (25th to 75th percentile) | 4.0 [2.0, 8.0] |
Low risk (< 5%) | 678 (50.4) |
Intermediate-high-risk (5 to < 20%) | 643 (47.8) |
High (≥ 20%) | 24 (1.8) |
Statin eligibilitya | 24 (1.8) |